AGP Executive Report
Last update: 11 hours agoCancer Care Update: NICE in England and Wales has recommended Henlius’ PD-1 inhibitor Hetronifly® (serplulimab) for routine NHS use in combination with standard chemotherapy for adults with extensive-stage small cell lung cancer. Pediatric Health: A new international imaging roadmap for pediatric portal hypertension lays out how ultrasound, Doppler, elastography, CT and MRI should guide diagnosis, classification and follow-up—aiming to reduce the “small adults” problem in care. Cardiology Evidence: Real-world MILOS analyses presented at ESC 2026 report that 1 year of bempedoic acid therapy was linked to lower predicted 10-year cardiovascular risk, with benefits across patient subgroups. Food Safety Alert: The FDA upgraded a recall of bettergoods pistachio nut butter to Class I risk over possible salmonella contamination, warning it could cause serious illness or death. Mental Health Prevention: A European framework urges training gym staff as early “sentinels” for eating disorder warning signs in young people. Italy Incident: A Belarusian cyclist was seriously injured in a crash in Vertova (Bergamo) and was flown to hospital.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.